The Full CIO Mandate:
Operations, Transformation & Strategy

The foundation of effective technology leadership is operational excellence: platforms that are available, compliant, secure, and cost-efficient. I have spent the majority of my career accountable for exactly this — leading global technology operations supporting one of the world's largest pharmaceutical businesses, with 800+ global shared services FTEs, hundreds of mission-critical systems, and zero tolerance for compliance gaps.

I maintained 100% audit success across SOX, HIPAA, GxP, and CMS across multi-year periods in a heavily regulated environment, building the processes, controls, and governance frameworks that made compliance a structural outcome rather than a periodic scramble. I also provided executive leadership during periods of operational disruption and crisis — ensuring continuity, transparency, and fast recovery.

Operational efficiency is equally a core strength. I drove 40%+ reductions in delivery and operating costs through shared services consolidation, vendor rationalization, and architecture standardization — not through one-time cuts, but through sustainable delivery models that maintained quality as they scaled.

Building an enterprise AI program that generates durable, auditable value requires far more than selecting the right models. It demands a strategy endorsed at the board level, a governance framework that connects investment decisions to business outcomes, and a value realization engine that holds every AI initiative accountable from kickoff through measurement.

I have designed and executed this system at scale — building an AI portfolio covering R&D, commercial, manufacturing, and enabling functions, supported by a $650M investment portfolio and a governance model that required >25% ROI and a 2-year payback across all global AI investments. This is AI built for enterprise accountability, not experimentation theater.

Key capabilities include: enterprise AI roadmap development, board and C-suite alignment, AI governance architecture, ROI and value measurement frameworks, generative AI deployment, and responsible AI principles integration.

Commercial technology in the pharmaceutical sector sits at a uniquely complex intersection: government pricing regulations, payer contracting mechanics, wholesaler relationships, specialty distribution models, and patient access programs — all requiring integrated, compliant, high-performance platforms.

I led technology strategy and operations for a $41B U.S. commercial engine — overseeing 500+ FTEs managing systems for wholesaler inventory planning, global pricing, payer contracts, rebates, chargebacks, government pricing, and patient services. My $150M revenue management transformation took a pharmaceutical company from worst-in-industry chargeback performance to "Supplier of the Year" recognition from major wholesalers.

Additional expertise includes performance-based payer contracting (risk-adjusted agreements across 36,000 physicians, PBMs, GPOs, and pharmacies), specialty pharmacy integration, and hub services transformation.

Enterprise ERP transformations are among the most complex, high-risk programs an organization can undertake — and among the most rewarding when executed with the right architecture, governance, and change management. I have directed multiple large-scale ERP and platform transformations spanning SAP, Salesforce, and Model N, standardizing global processes and driving operational excellence across commercial, finance, and supply chain organizations.

I also built the business case for and established Global Business Services organizations at scale — including an 800-FTE delivery center in India — reducing overall delivery and operating costs by 40%+ through standardized service models, vendor rationalization, and enterprise architecture discipline.

Experience covers the full transformation lifecycle: business case development, vendor selection, implementation governance, change management, post-go-live value realization, and Global Business Services design.

Drug shortage prediction, demand volatility forecasting, and DSCSA compliance aren't abstract technology problems — they have direct patient impact. I have deployed predictive AI models at enterprise scale to forecast drug shortages and demand volatility, strengthening supply chain resilience for one of the world's largest pharmaceutical portfolios.

This work extends to digital supply chain modernization: order management optimization, wholesaler engagement platforms, logistics technology, and the integration of compliance requirements (DSCSA, SOX, GxP) into operational architectures that move fast without introducing risk.

Technology capability without organizational readiness is technology theater. I have built and scaled an enterprise AI Academy from the ground up — achieving 3,000+ course completions, 350+ certified AI Champions across the organization, and a formal AI Certificate partnership with Stevens Institute of Technology that enrolled 500+ employees.

Beyond training programs, I have led the transformation of IT organizations from utility-mode delivery to product organizations — implementing OKR and Agile operating models that improved execution speed, efficiency, and business engagement by 30%. I also served in a commercial business rotation as a Brand Marketer for an oncology portfolio, giving me direct business-side perspective that informs how I build technology teams and align them to customer outcomes.